Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment.

Cancer biology & therapy

Volumn 6, Issue 8, 2007, Pages 1181-1185

  Gleysteen, John P ^a   Duncan, Ryan D ^a   Magnuson, J Scott ^a   Skipper, Joni B ^a   Zinn, Kurt ^a   Rosenthal, Eben L ^a  

^a Kentucky

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; DIAGNOSTIC AGENT; FLUORESCENT DYE; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CHEMISTRY; DRUG SCREENING; FLUORESCENCE MICROSCOPY; HEAD AND NECK TUMOR; HUMAN; LUMINESCENCE; MOUSE; MOUSE MUTANT; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; FLUORESCENT DYES; HEAD AND NECK NEOPLASMS; HUMANS; LUMINESCENT MEASUREMENTS; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 39749139571     PISSN: None     EISSN: 15558576     Source Type: Journal    
DOI: None     Document Type: Article

References (0)